Medibase
EN VI JA

DAV data · Drug recalls

Drugs recalled in Vietnam (DAV recall decisions)

Source: dav.gov.vn Last synced: 2026-05-21 Recall notices: 84

84 notices found. Showing 1–50.

Document № Drug Registration № Level Type Source
184/QD-QLD
2026-03-31
Aceclofenac STELLA 100mg
Decision No. 184/QD-QLD on the recall of Aceclofenac STELLA 100mg due to a level 2 violation (Reg. No.: VD-20124-13)
VD-20124-13 Level 2 Quality violation
152/QD-QLD
2026-03-24
Aclon
Decision No. 152/QD-QLD on the recall of Aclon due to a level 2 violation (Reg. No.: VD-18521-13)
VD-18521-13 Level 2 Quality violation
46/QD-QLD
2026-01-26
Diacerin 50
Decision No. 46/QD-QLD on the recall of Diacerin 50 due to a level 3 violation (Reg. No.: 893110447024)
893110447024 Level 3 Quality violation
735/QD-QLD
2025-12-10
Diclofen
Decision No. 735/QD-QLD on the recall of Diclofen due to a level 2 violation (Reg. No.: VD-25150-16)
VD-25150-16 Level 2 Quality violation
696/QD-QLD
2025-11-25
Padobaby
Decision No. 696/QD-QLD on the recall of Padobaby due to a level 3 violation (Reg. No.: 893100414024 (old Reg. No.: VD-32292-19))
893100414024 Level 3 Quality violation
554/QD-QLD
2025-10-14
Pyfaclor Kid granules for oral suspension
Decision No. 554/QD-QLD on the recall of Pyfaclor Kid granules for oral suspension, Reg. No.: VD-26427-17
VD-26427-17 — Other
475/QD-QLD
2025-09-29
Pyfaclor Kid
Decision No. 475/QD-QLD on the recall of Pyfaclor Kid due to a level 2 violation (Reg. No.: VD-26427-17)
VD-26427-17 Level 2 Quality violation
358/QD-QLD
2025-07-17
Femancia
Decision No. 358/QD-QLD on the recall of Femancia, Reg. No.: VD-27929-17
VD-27929-17 — Other
1778/QLD-CL
2025-06-22
Alfachim 4.2 tablets
Official Letter No. 1778/QLD-CL on the notification of the recall of a drug with a level 2 violation (Alfachim 4.2 tablets (Chymotrypsin (equivalent to 21 microkatal chymotrypsin) 4200 IU), Reg. No.: VD-34573-20, Batch no.: 03010624; Mfg. date: 01/06/2024; Exp.: 01/06/2026)
VD-34573-20 Level 2 Quality violation
1513/QLD-CL
2025-06-04
Eye drops
Official Letter No. 1513/QLD-CL on the notification of the recall of a drug with a level 3 violation (Ofleye Drops eye and ear drops solution (Ofloxacin 0.3%), Reg. No.: 893115586524 (old Reg. No.: VD-32740-19), Batch no.: 011024; Mfg. date: 25/10/2024; Exp.: 24/10/2027)
893115586524 Level 3 Quality violation
1245/QLD-CL
2025-04-29
Tegrucil-1 tablets
Official Letter No. 1245/QLD-CL on the notification of the recall of a drug with a level 3 violation (Tegrucil-1 tablets (Acenocoumarol 1mg), Reg. No.: VD-27453-17, Batch no.: 241600, Mfg. date: 01/07/2024, Exp.: 01/07/2027)
VD-27453-17 Level 3 Quality violation
841/QLD-CL
2025-03-19
Pyfaclor Kid granules for oral suspension
Official Letter No. 841/QLD-CL on the notification of the recall of a drug with a level 3 violation (Pyfaclor Kid granules for oral suspension (Cefaclor 125mg), Reg. No.: VD-26427-17, Batch no.: 330823, Mfg. date: 10823, Exp.: 210826; Batch no.: 050124, Mfg. date: 250124, Exp.: 250127)
VD-26427-17 Level 3 Quality violation
712/QLD-CL
2025-03-05
Femancia hard capsules
Official Letter No. 712/QLD-CL on the notification of the recall of a drug with a level 2 violation (Femancia hard capsules (Elemental iron (as ferrous fumarate 305 mg) 100 mg; Folic acid 350 mcg), Reg. No.: VD-27929-17)
VD-27929-17 Level 2 Quality violation
685/QLD-CL
2025-02-28
Erythromycin 500mg film-coated tablets
Official Letter No. 685/QLD-CL on the notification of the recall of a drug with a level 2 violation (Erythromycin 500mg film-coated tablets (Erythromycin 500mg), Reg. No.: VD-31437-19, Batch no.: 022024, Mfg. date: 15/06/2024, Exp.: 15/06/2028)
VD-31437-19 Level 2 Quality violation
3716/QLD-CL
2024-11-13
Prednisolon 5mg tablets
Official Letter No. 3716/QLD-CL on the notification of the recall of a drug with a level 3 violation (Prednisolon 5mg tablets (Prednisolon 5mg), Reg. No.: VD-27065-17, Batch no.: 020523, Mfg. date: 10/05/23, Exp.: 10/05/26, manufactured by Tipharco Pharmaceutical JSC)
VD-27065-17 Level 3 Quality violation
3114/QLD-CL
2024-09-17
Reinal-5 hard capsules
Official Letter No. 3114/QLD-CL on the notification of the recall of a drug with a level 2 violation (Reinal-5 hard capsules (Flunarizin 5mg), Reg. No.: VD-30346-18, Batch no.: 240256; Mfg. date: 20/02/2024; Exp.: 20/02/2027, manufactured by Dat Vi Phu Pharmaceutical JSC)
VD-30346-18 Level 2 Quality violation
3105/QLD-CL
2024-09-16
Compacin powder for oral suspension
Official Letter No. 3105/QLD-CL on the notification of the recall of a drug with a level 2 violation (Compacin powder for oral suspension (Ciprofloxacin 250mg), Reg. No.: VD-29775-18, Batch no.: 011123, Mfg. date: 02/11/23, Exp.: 02/11/26, manufactured by Medisun Pharmaceutical JSC)
VD-29775-18 Level 2 Quality violation
3007/QLD-CL
2024-09-09
Cetecocenzitax tablets
Official Letter No. 3007/QLD-CL on the notification of the recall of a drug with a level 3 violation (Cetecocenzitax tablets (Cinarizin 25mg), Reg. No.: VD-20384-13, Batch no.: 01/0823, Mfg. date: 030823, Exp.: 030826, manufactured by Central Pharmaceutical JSC No. 3)
VD-20384-13 Level 3 Quality violation
3005/QLD-CL
2024-09-09
Zovitit capsules containing microgranules
Official Letter No. 3005/QLD-CL on the notification of the recall of a drug with a level 2 violation (Zovitit capsules containing microgranules (Acyclovir 200mg), Reg. No.: VN-15819-12, Batch no.: 0017, Mfg. date: 03/05/23, Exp.: 02/05/26, manufactured by S.C. Slavia Pharma S.R.L (Romania)
VN-15819-12 Level 2 Quality violation
2825/QLD-CL
2024-08-19
Cefaclor 375mg film-coated oblong tablets
Official Letter No. 2825/QLD-CL on the notification of the recall of a drug with a level 2 violation (Cefaclor 375mg film-coated oblong tablets (Cefaclor), Reg. No.: VD-14047-11, Batch no.: 0124, Mfg. date: 23/01/24, Exp.: 23/01/27, manufactured by the branch of Medical Pharmaceutical and Biological JSC)
VD-14047-11 Level 2 Quality violation
1310/QLD-CL
2024-05-09
Temozolomid Ribosepharm 100 mg
Official Letter No. 1310/QLD-CL on the notification of the recall of a drug with a level 3 violation (Temozolomid Ribosepharm 100 mg, Reg. No. VN2-626-17, Batch no.: 2J6001, Mfg. date: 17/8/2022, Exp.: 31/8/2025)
VN2-626-17 Level 3 Quality violation
627/QLD-CL
2024-02-28
Xylometazolin 0.05% nasal drops solution
Official Letter No. 627/QLD-CL on the notification of the recall of a drug with a level 2 violation (Xylometazolin 0.05% nasal drops solution, Reg. No.: VD-18682-13, Batch no.: 030523, Mfg. date: 19/05/2023, Exp.: 19/05/2025)
VD-18682-13 Level 2 Quality violation
598/QLD-CL
2024-02-26
Fluconazole hard capsules
Official Letter No. 598/QLD-CL on the notification of the recall of a drug with a level 3 violation (Fluconazole hard capsules (Fluconazole 150mg), Reg. No.: VN-16474-13, Batch no.: KE22638; Mfg. date: 10/10/2022; Exp.: 09/10/2025)
VN-16474-13 Level 3 Quality violation
384/QLD-CL
2024-02-06
Cetirizin film-coated tablets
Official Letter No. 384/QLD-CL on the notification of the recall of a drug with a level 3 violation (Cetirizin film-coated tablets (Cetirizin hydroclorid 10mg), Reg. No.: VD-20648-14, Batch no.: 21002B, Mfg. date: 250521, Exp.: 250524; Batch no.: 21001B, Mfg. date: 140421, Exp.: 140424)
VD-20648-14 Level 3 Quality violation
9358/QLD-CL
2023-09-08
PymeRoxitil film-coated tablets
Official Letter No. 9358/QLD-CL on the notification of the recall of a drug with a level 2 violation (PymeRoxitil film-coated tablets (Roxithromycin 150mg), Reg. No.: VD-28304-17, Batch no.: 010522, Mfg. date: 18/05/2022, Exp.: 18/05/2025)
VD-28304-17 Level 2 Quality violation
9058/QLD-CL
2023-08-21
H-inzole hard capsules
Official Letter No. 9058/QLD-CL on the notification of the recall of a drug with a level 3 violation (H-inzole hard capsules, Reg. No.: VN-18555-14, Batch no.: HT4-51, Mfg. date: 18/10/2022, Exp.: 17/10/2024)
VN-18555-14 Level 3 Quality violation
8895/QLD-CL
2023-08-10
Paineuron 15 tablets
Official Letter No. 8895/QLD-CL on the notification of the recall of a drug with a level 3 violation (Paineuron 15 tablets (Meloxicam 15mg), Reg. No.: VD-32650-19, Batch no.: 83034, Mfg. date: 29/01/2023, Exp.: 28/01/2026)
VD-32650-19 Level 3 Quality violation
5834/QLD-CL
2023-06-01
Duo Hexin Tab
Official Letter No. 5834/QLD-CL on the notification of the recall of Duo Hexin Tab due to a level 2 violation
— Level 2 Quality violation
2205/QLD-CL
2023-03-10
Locobile-200 hard capsules
Official Letter No. 2205/QLD-CL on the notification of the recall of a drug with a level 3 violation (Locobile-200 hard capsules (Celecoxib 200mg), Reg. No.: VN-21822-19, Batch no.: WLD21003E, Mfg. date: 04/02/2021, Exp.: 03/02/2024)
VN-21822-19 Level 3 Quality violation
1223/QLD-CL
2023-02-10
Tobradico
Official Letter No. 1223/QLD-CL on the notification of the recall of Tobradico ((Tobramycin (as Tobramycin sulfat) 15mg/5ml), Reg. No.: VD-19202-13, Batch no.: 0031022, Mfg. date: 02/10/2022, Exp.: 02/10/2024)
VD-19202-13 — Other
424/QLD-CL
2023-01-16
Myomethol
Official Letter No. 424/QLD-CL on the notification of the recall of substandard Myomethol
— — Quality violation
13598/QLD-CL
2022-12-26
Rabesta 20 gastro-resistant tablets
Official Letter No. 13598/QLD-CL on the notification of the recall of a drug with a level 2 violation (Rabesta 20 gastro-resistant tablets (Rabeprazol sodium 20mg))
— Level 2 Quality violation
13223/QLD-CL
2022-12-14
Levosum
Official Letter No. 13223/QLD-CL on the notification of the recall of Levosum
— — Other
13021/QLD-CL
2022-12-07
Npluvico
Official Letter No. 13021/QLD-CL on the notification of the recall of Npluvico due to a level 2 violation
— Level 2 Quality violation
12290/QLD-CL
2022-11-18
Greaxim 2g powder for injection
Official Letter No. 12290/QLD-CL on the notification of the recall of Greaxim 2g powder for injection, VD-33386-19 and Greaxim powder for injection, VD-18235-13
— — Other
10275/QLD-CL
2022-10-13
Batiwell
Official Letter No. 10275/QLD-CL on the recall of Batiwell, batch no. 00121
— — Other
9586/QLD-CL
2022-09-29
Batiwell oral solution
Official Letter No. 9586/QLD-CL on the recall of a substandard drug (Batiwell oral solution (Bromhexin hydroclorid 0.8mg/ml), Reg. No.: VD-31011-18, Control no.: 00121, Mfg. date: 08/03/2021, Exp.: 08/03/2024)
VD-31011-18 — Quality violation
9343/QLD-CL
2022-09-22
Official Letter No. 9343/QLD-CL on the notification of a drug recall
— — Other
6298/QLD-CL
2022-07-14
Capetero 500 film-coated tablets
Official Letter No. 6298/QLD-CL on the notification of the recall of a drug with a level 2 violation (Capetero 500 film-coated tablets (Capecitabine 500mg))
— Level 2 Quality violation
6125/QLD-CL
2022-07-13
Nutrohadi F oral syrup
Official Letter No. 6125/QLD-CL on the notification of the recall of a drug with a level 2 violation (Nutrohadi F oral syrup, Reg. No.: VD- 18684-13, Batch no.: 030221; Mfg. date: 240221; Exp.: 230224)
— Level 2 Quality violation
5667/QLD-CL
2022-06-30
Neometin tablets
Official Letter No. 5667/QLD-CL on the notification of the recall of a drug with a level 2 violation (Neometin tablets (Metronidazol 500mg; Neomycin sulphat 108.3mg; Nystatin 22.73mg))
— Level 2 Quality violation
3534/QLD-CL
2022-05-09
Zinnat Suspension 125mg granules for oral suspension
Official Letter No. 3534/QLD-CL on the notification of the recall of a drug with a level 2 violation (Zinnat Suspension 125mg granules for oral suspension (Cefuroxim axetil 125mg))
— Level 2 Quality violation
3447/QLD-CL
2022-05-04
Neurobion sugar-coated tablets
Official Letter No. 3447/QLD-CL on the notification of the recall of a drug with a level 3 violation (Neurobion sugar-coated tablets (Pyridoxin HCl (vitamin B6) 200mg; Vitamin B1 (Thiamin mononitrat) 100mg; Vitamin B12 (Cyanocobalamin) 200mcg))
— Level 3 Quality violation
2984/QLD-CL
2022-04-19
Navacarzol tablets
Official Letter No. 2984/QLD-CL on the notification of the recall of a drug with a level 2 violation (Navacarzol tablets (Carbimazole 5mg))
— Level 2 Quality violation
14458/QLD-CL
2021-12-08
Methotrexat Bidiphar 50mg/2ml
Official Letter No. 14458/QLD-CL on the recall of a batch of Methotrexat Bidiphar 50mg/2ml failing to meet quality standards
— — Quality violation
12887/QLD-CL
2021-10-21
NOVOTEC - 70 tablets
Official Letter No. 12887/QLD-CL on the notification of the recall of a drug with a level 2 violation (NOVOTEC - 70 tablets)
— Level 2 Quality violation
9764/QLD-CL
2021-08-20
Hoat Huyet Duong Nao sugar-coated tablets
Official Letter No. 9764/QLD-CL on the notification of the recall of a drug with a level 2 violation (Hoat Huyet Duong Nao sugar-coated tablets)
— Level 2 Quality violation
9171/QLD-CL
2021-08-06
Vitamin C 300mg film-coated tablets
Official Letter No. 9171/QLD-CL on the notification of the recall of a drug with a level 3 violation (Vitamin C 300mg film-coated tablets)
— Level 3 Quality violation
9155/QLD-CL
2021-08-05
Sucrate gel oral suspension
Official Letter No. 9155/QLD-CL on the notification of the recall of a drug with a level 3 violation (Sucrate gel oral suspension (Sucralfate 1g/5ml))
— Level 3 Quality violation
8968/QLD-CL
2021-07-30
Amoxicillin 500mg
Official Letter No. 8968/QLD-CL on the handling of substandard Amoxicillin 500mg
— — Quality violation

Reference data. Decision number, drug name, registration number and violation level are parsed automatically from each notice title, so some notices may leave these fields blank. Verify against the signed recall decision PDF before relying on it for legal purposes.

Services by MTC

Need help with pharmacovigilance?

Handled by MTC Consulting & Trading Co., Ltd, the team behind Medibase — medibase@mtcorp.vn

About this data

The Drug Administration of Vietnam (DAV) issues recall decisions for drugs pulled from the market — for a quality violation, a voluntary recall, or a withdrawal of the marketing authorisation. Quality violations are graded level 1–3 (level 1 is the most serious). Compiled from the DAV cn89 listing.